Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 020655

Expand all

ALORA (ESTRADIOL)
0.025MG/24HR
Marketing Status: Discontinued

Active Ingredient: ESTRADIOL
Proprietary Name: ALORA
Dosage Form; Route of Administration: FILM, EXTENDED RELEASE; TRANSDERMAL
Strength: 0.025MG/24HR
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N020655
Product Number: 004
Approval Date: Apr 5, 2002
Applicant Holder Full Name: ABBVIE INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

ALORA (ESTRADIOL)
0.05MG/24HR
Marketing Status: Discontinued

Active Ingredient: ESTRADIOL
Proprietary Name: ALORA
Dosage Form; Route of Administration: FILM, EXTENDED RELEASE; TRANSDERMAL
Strength: 0.05MG/24HR
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N020655
Product Number: 001
Approval Date: Dec 20, 1996
Applicant Holder Full Name: ABBVIE INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

ALORA (ESTRADIOL)
0.075MG/24HR
Marketing Status: Discontinued

Active Ingredient: ESTRADIOL
Proprietary Name: ALORA
Dosage Form; Route of Administration: FILM, EXTENDED RELEASE; TRANSDERMAL
Strength: 0.075MG/24HR
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N020655
Product Number: 002
Approval Date: Dec 20, 1996
Applicant Holder Full Name: ABBVIE INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

ALORA (ESTRADIOL)
0.1MG/24HR
Marketing Status: Discontinued

Active Ingredient: ESTRADIOL
Proprietary Name: ALORA
Dosage Form; Route of Administration: FILM, EXTENDED RELEASE; TRANSDERMAL
Strength: 0.1MG/24HR
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N020655
Product Number: 003
Approval Date: Dec 20, 1996
Applicant Holder Full Name: ABBVIE INC
Marketing Status:  Discontinued
Patent and Exclusivity Information